Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
NYSE MKT:OGEN
Oragenics (OGEN) Stock Price & Analysis
919 Followers
OGEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.60 - $12.04
Previous Close$3.74
Volume43.50K
Average Volume (3M)16.56K
Market Cap
$8.63M
Enterprise Value$3.38M
Total Cash (Recent Filing)$5.77M
Total Debt (Recent Filing)$517.76K
Price to Earnings (P/E)-0.8
Beta0.94
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.67
Shares Outstanding2,569,385
10 Day Avg. Volume6,540
30 Day Avg. Volume16,562
Standard Deviation0.26
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.76
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue89.88
Enterprise Value/Gross Profit25.73
Enterprise Value/Ebitda-0.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oragenics News
Ownership Overview
1.33% Insiders
1.12% Mutual Funds
0.36% Other Institutional Investors
97.20% Public Companies and
Individual Investors
OGEN FAQ
What was Oragenics Inc’s price range in the past 12 months?
Oragenics Inc lowest stock price was $2.60 and its highest was $12.04 in the past 12 months.
What is Oragenics Inc’s market cap?
Currently, no data Available
When is Oragenics Inc’s upcoming earnings report date?
Oragenics Inc’s upcoming earnings report date is May 13, 2024 which is in 157 days.
How were Oragenics Inc’s earnings last quarter?
Oragenics Inc released its earnings results on Aug 14, 2023. The company reported -$1.507 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.507.
Is Oragenics Inc overvalued?
According to Wall Street analysts Oragenics Inc’s price is currently Overvalued.
Does Oragenics Inc pay dividends?
Oragenics Inc does not currently pay dividends.
What is Oragenics Inc’s EPS estimate?
Oragenics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oragenics Inc have?
Oragenics Inc has 2,569,385 shares outstanding.
What happened to Oragenics Inc’s price movement after its last earnings report?
Oragenics Inc reported an EPS of -$1.507 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.627%.
Which hedge fund is a major shareholder of Oragenics Inc?
Currently, no hedge funds are holding shares in OGEN
---
Oragenics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
OGEN Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $12.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-67.10%
12-Months-Change
Fundamentals
Return on Equity
-93.21%
Trailing 12-Months
Asset Growth
-53.67%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Oragenics Inc
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
---
Top 5 ETFs holding OGEN
iShares Core S&P Total U.S. Stock Market ETF
$3.72K
Up to five ETFs with an Outperform Smart Score that hold OGEN. The ETFs are listed according to market value of OGEN within the ETF
---